Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors (Q35023503)

5 August 2017

Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors (English)

1 reference

5 August 2017

1

Giuseppe Giaccone

1 reference

5 August 2017

Eva Szabo

5

1 reference

ORCID Public Data File 2021

Jane B Trepel

7

object named as

Jane Trepel

1 reference

5 August 2017

Arun Rajan

2

1 reference

5 August 2017

Arlene Berman

3

1 reference

5 August 2017

Ronan J Kelly

4

1 reference

5 August 2017

Ariel Lopez-Chavez

6

1 reference

5 August 2017

Min-Jung Lee

8

1 reference

5 August 2017

Liang Cao

9

1 reference

5 August 2017

Igor Espinoza-Delgado

10

1 reference

5 August 2017

John Spittler

11

1 reference

5 August 2017

Patrick J Loehrer

12

1 reference

5 August 2017

language of work or name

English

0 references

publication date

18 April 2011

1 reference

Journal of Clinical Oncology

5 August 2017

1 reference

5 August 2017

29

1 reference

5 August 2017

15

1 reference

5 August 2017

2052-2059

1 reference

Expression and mutational status of c-kit in thymic epithelial tumors

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

FOXP3+ regulatory T cells in the human immune system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Inside HDAC with HDAC inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Treatment of advanced thymoma and thymic carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Clinical management of thymoma patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Assays for pharmacodynamic analysis of histone deacetylase inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Mutational status of EGFR and KIT in thymoma and thymic carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107761

The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients

25 October 2018

1 reference

12 December 2020

Primary thymic carcinoma

1 reference

12 December 2020

Oligoclonal peripheral T-cell lymphocytosis as a result of aberrant T-cell development in a cortical thymoma

1 reference

12 December 2020

Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors

1 reference

12 December 2020

Thymoma-associated paraneoplastic polymyositis

1 reference

12 December 2020

Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2010.32.4467

1 reference

5 August 2017

1 reference

5 August 2017

1 reference